Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Partners in Prevention Study: Acyclovir for HSV-2 Suppression to Prevent HIV Transmission
NCT00194519Phase 3Completed
- Sponsor
- University of Washington
- Start
- Nov 2004
- Primary completion
- Nov 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Acyclovir with Placebo (2 arms). Primary endpoint: Sequence-verified HIV-transmission from index to partner participant. Started Nov 2004; status: completed.
02
Drugs
aciclovir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00194519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194519.